Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris - Contacts and Locations

Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

This study has been completed.

Study NCT00671749. Last updated on September 5, 2008. Information provided by Galderma Laboratories, L.P.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00671749

Locations


United States, California
	Center for Dermatology and Laser Surgery
	Sacramento, California, United States, 95819

United States, Kentucky
	Derm Research, P.L.L.C.
	Louisville, Kentucky, United States, 40217

United States, Ohio
	Brodell Medical
	Warren, Ohio, United States, 44483

United States, Oregon
	Northwest Cutaneous Research Specialists
	Portland, Oregon, United States, 97210

Sponsors and Collaborators

Galderma Laboratories, L.P.

Investigators


Study Director:	Ron W Gottschalk, MD	Galderma Laboratories, L.P.